OTCM
CLABF
Market cap0kUSD
May 15, Last price
0.00USD
Name
Core One Labs Inc
Chart & Performance
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
142.58%
Revenues
648k
+50.15%
Net income
-16m
L-56.88%
CFO
-2m
L-56.99%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Core One Labs Inc. functions as a biotechnology research and life sciences firm. Its primary objective involves bringing psychedelic medications to the market, employing several key strategies. These include developing innovative delivery methods, offering psychedelic-assisted psychotherapy, and manufacturing API-grade psilocybin. The company also developed CannaStrips technology, which facilitates the bioavailability of cannabis compounds through infused strips. Complementing its core activities, Core One Labs provides a range of additional services such as consulting, financing, and micro cultivation support. It further operates medical and wellness clinics, supplies natural health products, and offers news dissemination services. Established in 2010, the company, formerly known as Lifestyle Delivery Systems Inc., adopted its current name in September 2019 and is headquartered in Vancouver, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑03 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||